Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Quick Stats
Jan 30, 202644.4
AI Score
HOLD0.93
Volume Ratio
Feb 26, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
CLDX Stock Summary
Last updated Jan 30, 2026
CLDX is currently trading at $24.6, positioned above its 200-day moving average of $23.66, indicating a long-term uptrend. The stock has a 52-week range of $14.4 to $30.5.
Technical Analysis: The 50-day moving average stands at $26.56, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.848, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.068, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CLDX at 44.4/100 with a HOLD recommendation.
CLDX (Celldex Therapeutics, Inc) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.848 |
| CMF (20) | -0.068 |
| ROC (10) | -4.243 |
| ADX (14) | 10.898 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.383 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -80.0 |
| MFI (14) | 37.505 |
CLDX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CLDX Price vs Max Options Open Interest
CLDX Max Change In Options Open Interest
CLDX Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CLDX Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CLDX Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CLDX Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Celldex Therapeutics, Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CLDX Moving Averages Analysis
Celldex Therapeutics, Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
CLDX (Celldex Therapeutics, Inc) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 25.68 |
| 20 | 26.09 |
| 30 | 26.18 |
| 50 | 26.56 |
| 100 | 26.08 |
| 200 | 23.66 |
CLDX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.6 billion |
| Earnings/Share ($) | -3.38 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.5886 |
| EPS Estimate Next Year ($) | -4.4181 |
| WallStreet Target Price ($) | 53.3571 |
| Most Recent Quarter |